The pathogenesis of psoriasis: immunological facts and speculations (Q33542328)

27 July 2017

1 reference

title

The pathogenesis of psoriasis: immunological facts and speculations (English)

1 reference

27 July 2017

0 references

Bos JD

1

1 reference

PubMed ID

10081229

27 July 2017

De Rie MA

series ordinal

2

1 reference

27 July 2017

1 January 1999

1 reference

27 July 2017

1 reference

27 July 2017

20

1 reference

27 July 2017

40-46

1 reference

27 July 2017

1

1 reference

Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

New concepts in the pathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Use of cyclosporin in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Beneficial clinical effects of cyclosporin A on severe psoriasis and its dissociation from serum concentration of soluble interleukin-2 receptor, soluble interleukin-6 receptor, soluble CD14 antigen, soluble intercellular adhesion molecule-1, and so

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

The puzzling genetics of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Do specific pockets of HLA-C molecules predispose Jewish patients to psoriasis vulgaris?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

The genetics of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Evidence that a locus for familial psoriasis maps to chromosome 4q

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Altered keratinocyte growth and differentiation in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Signal transduction pathways in epidermal proliferation and cutaneous inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated Response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

T cells involved in psoriasis vulgaris belong to the Th1 subset

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

RT-PCR topography of chronic psoriasis skin based on analysis of T-cell receptor B variable region gene usage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Selective amplification of T-cell receptor variable region species is demonstrable but not essential in early lesions of psoriasis vulgaris: analysis by anchored polymerase chain reaction and hypervariable region size spectratyping.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinoc

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Dermal injection of immunocytes induces psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Psoriasis after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Interferon Gamma-Treated Keratinocytes Activate T Cells in the Presence of Superantigens: Involvement of Major Histocompatibility Complex Class II Molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

ACUTE GUTTATE PSORIASIS AND STREPTOCOCCAL INFECTION

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901381-4

7 January 2021

10.1016/S0167-5699(98)01381-4

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

10081229